# The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients"

> **NCT05300841** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sohag University** · enrollment: 500 (estimated)

## Conditions studied

- PCOS
- ICSI

## Interventions

- **DRUG:** dydrogesterone 20 mg /d (Duphaston, Abott Healthcare , Egypt)
- **DRUG:** estradiol valerate 2 mg /d (white tablets of cycloprognova, Bayer Shering, Germany)

## Key facts

- **NCT ID:** NCT05300841
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05300841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05300841, "The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients"". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05300841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*